Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
21,271
21,156
20,993
22,232
19,687
17,534
Hasılat Artışı (YoY)
1%
1%
-6%
13%
12%
9%
Satınalma Maliyeti
8,787
8,579
8,370
8,413
7,325
6,782
Brüt Kâr
12,484
12,577
12,623
13,819
12,362
10,752
Satış, Genel ve İdari
5,998
5,161
5,067
5,257
4,855
4,600
Araştırma ve Geliştirme
2,277
2,268
2,438
2,446
2,400
2,262
İşletme Giderleri
8,542
8,214
8,451
8,564
7,998
7,682
Diğer Finansman Gelirleri (Giderleri)
--
-11
-2
7
0
-5
Kâr Öncesi Gelir
3,716
3,536
3,484
4,287
3,924
2,630
Kira Vergisi Gideri
758
751
650
948
859
637
Net Kâr
2,955
2,777
2,824
3,326
3,055
1,987
Net Income Growth
Kâr Artışı
10%
-2%
-15%
9%
54%
51%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
435.74
434.77
434.77
434.77
434.56
434.79
Hisse Değişimi (Yıllık Üst Üste)
0%
0%
0%
0%
0%
0%
EPS (Diluted)
6.79
6.38
6.49
7.64
7.03
4.57
EPS Artışı
9%
-2%
-15%
9%
54%
51%
Öz sermaye akışı
1,933
2,402
1,761
2,453
3,195
1,914
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
58.69%
59.44%
60.12%
62.15%
62.79%
61.32%
Faaliyet Kâr Marjı
18.53%
20.62%
19.87%
23.63%
22.16%
17.5%
Kâr Marjı
13.89%
13.12%
13.45%
14.96%
15.51%
11.33%
Özsermaye Karlılık Oranı
9.08%
11.35%
8.38%
11.03%
16.22%
10.91%
EBITDA
5,881
6,497
6,052
7,285
6,126
5,008
EBITDA Marjinali
27.64%
30.7%
28.82%
32.76%
31.11%
28.56%
D&A EBITDA için
1,939
2,134
1,880
2,030
1,762
1,938
Faaliyet Kârı
3,942
4,363
4,172
5,255
4,364
3,070
Faaliyet Kâr Marjı
18.53%
20.62%
19.87%
23.63%
22.16%
17.5%
Verilen Vergi Oranı
20.39%
21.23%
18.65%
22.11%
21.89%
24.22%
Önemli İstatistikler
Önceki Kapanış
$29.83
Açılış fiyatı
$30.45
Günün Aralığı
$30.25 - $30.65
52 haftalık aralık
$24.32 - $31
İşlem hacmi
3.2K
Ort.Hacim
117.2K
EPS (TTM)
1.59
Dividend yield
--
Piyasa Değeri
$13.2B
Merck KGaA nedir?
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 62,346 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.